Enhanced Sensitivity of a Second Generation ELISA for Antibody to Hepatitis C Virus
- 1 May 1992
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 62 (4) , 213-217
- https://doi.org/10.1111/j.1423-0410.1992.tb01201.x
Abstract
A second generation ELISA for combined detection of antibodies to three hepatitis C virus (HCV) recombinant proteins, i.e. C100, C33c and core, was compared with a first generation anti-HCV ELISA in which only antibodies to C100 are detected. The results of the ELISAs were evaluated in 225 haemophilia patients (panel A) and 44 patients with non-A, non-B (NANB) hepatitis (panel B). HCV infection was established by cDNA-polymerase chain reaction (PCR) (in panel B only) and by studying the anti-HCV reaction patterns in 4 separate ELISAs for detection of antibodies to the recombinant proteins C100, C33c, core and a combination of two synthetic peptides sp67/65 derived from the C100 region. The sensitivity for the detection of HCV infection had increased from 0.92[95% confidence interval (CI): 0.87-0.95] to 1.00 (95% CI: 0.89-1.00) in haemophiliacs and from 0.84 (95% CI: 0.66-0.95) to 1.00 (95% CI: 0.89-1.00) in NANB hepatitis patients when the second generation ELISA was used instead of the first generation ELISA. Concurrently the chance of a false negative result was reduced in panel A and B from 0.37 to 0 and from 0.28 to 0, respectively. Analysis of anti-HCV reaction patterns revealed that 172 of 206 (83.5%) anti-HCV ELISA-reactive haemophilia patients had antibodies to all 4 antigens tested. In the NANB hepatitis patients 18 of 31 (58.1%) anti-HCV ELISA-reactive subjects reacted with 4 antigens. In the PCR tested panel of NANB hepatitis patients 2 subjects who showed antibody reactivity to only one antigen and 5 patients with reactivity to 2 antigens were PCR-positive.(ABSTRACT TRUNCATED AT 250 WORDSKeywords
This publication has 18 references indexed in Scilit:
- Second-generation RIBA to confirm diagnosis of HCV infectionThe Lancet, 1991
- Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction.Journal of Clinical Investigation, 1990
- Hepatitis C virus RNA in symptomless donors implicated in post-transfusion non-A, non-B hepatitisThe Lancet, 1990
- Anti-HCV and transaminase testing of blood donorsThe Lancet, 1990
- Detection of hepatitis C viral sequences in non-A, non-B hepatitisThe Lancet, 1990
- Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1989
- ANTIBODIES TO HEPATITIS C VIRUS IN NON-A, NON-B POST-TRANSFUSION AND CRYPTOGENETIC CHRONIC LIVER DISEASEThe Lancet, 1989
- ANTI-HEPATITIS C ANTIBODIES AND NON-A, NON-B POST-TRANSFUSION HEPATITIS IN THE NETHERLANDSThe Lancet, 1989
- HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAINThe Lancet, 1989
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989